India's drug controller approves Psoriasis injection Itolizumab for limited use in treating COVID-19

Psoriasis injection Itolizumab, which is used to cure skin ailment, has been approved for limited use in treating coronavirus, Drug Controller General of India (DCGI) has said. India's drug controller has okayed emergency use of Psoriasis injection for treating COVID-19 patients with moderate to severe acute respiratory distress.

from IndiaTV India: Google News Feed

Get Breaking news, Live news, and latest news from India and around the world on, which are in the interest of nation and humanity. Like us on Facebook or Follow us on Twitter and Reddit for the latest news blog and live news update

Trending News